Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHSEN S ARANI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1821097072
CMS profile
127522
Location
THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$30,225.60

363 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $21,355.00 5
Food and Beverage $8,825.33 357
Education $45.27 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $20,405.89 12
Kite Pharma, Inc. $1,635.53 4
AstraZeneca Pharmaceuticals LP $612.56 21
US Oncology Corporate, Inc. $596.47 3
Janssen Biotech, Inc. $462.55 21
PFIZER INC. $449.40 22
Novartis Pharmaceuticals Corporation $436.69 29
ABBVIE INC. $374.70 15
Celgene Corporation $369.51 16
E.R. Squibb & Sons, L.L.C. $359.64 28
Eisai Inc. $347.55 12
GENZYME CORPORATION $303.50 12
RECORDATI_RARE_DISEASES_INC. $286.54 6
Dendreon Pharmaceuticals LLC $261.84 10
Daiichi Sankyo Inc. $258.43 16
Merck Sharp & Dohme LLC $231.58 11
Lilly USA, LLC $221.07 9
JAZZ PHARMACEUTICALS INC. $198.68 6
SOBI, INC $170.75 6
GlaxoSmithKline, LLC. $158.25 7
Genentech USA, Inc. $156.01 8
Gilead Sciences, Inc. $147.32 7
Takeda Pharmaceuticals U.S.A., Inc. $147.23 6
Blueprint Medicines Corporation $136.93 5
Celltrion USA Inc. $104.90 5
Incyte Corporation $93.18 5
Regeneron Healthcare Solutions, Inc. $88.64 4
PUMA BIOTECHNOLOGY, INC. $85.01 5
Mirati Therapeutics, Inc. $82.22 4
TAIHO ONCOLOGY, INC. $77.61 3
Apellis Pharmaceuticals, Inc. $69.33 2
Karyopharm Therapeutics Inc. $68.77 4
Stemline Therapeutics Inc. $64.21 3
PharmaEssentia USA Corporation $60.08 3
Rigel Pharmaceuticals, Inc. $58.55 3
Tempus AI, Inc $58.46 3
Pharmacosmos Therapeutics Inc. $57.75 2
TerSera Therapeutics LLC $57.21 2
EMD Serono, Inc. $48.67 2
Legend Biotech USA Inc. $44.12 2
ADC Therapeutics America, Inc. $43.53 2
BeiGene USA, Inc. $37.58 2
Immunocore Limited $36.05 1
Ipsen Biopharmaceuticals, Inc $32.02 2
Coherus Biosciences Inc. $28.35 2
Boehringer Ingelheim Pharmaceuticals, Inc. $28.19 1
ImmunoGen, Inc. $27.37 1
MorphoSys, US Inc. $23.19 1
Deciphera Pharmaceuticals Inc. $22.27 1
Secura Bio, Inc. $21.49 1
Janssen Pharmaceuticals, Inc $18.54 1
Adaptive Biotechnologies Corporation $16.94 1
Fresenius Kabi USA, LLC $16.21 1
Pharming Healthcare, Inc. $14.64 1
Acrotech Biopharma Inc. $11.90 1

Page 7 of 8; records 301–350 of 363 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHSEN S ARANI

NPI 1821097072 · CMS profile ID 127522

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 7 of 8; records 301–350 of 363 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821097072?year=2024&recipient=provider&page=7#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 8; records 301–350 of 363 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821097072?year=2024&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 8; records 301–350 of 363 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821097072?year=2024&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 7 of 8; records 301–350 of 363 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1821097072?year=2024&recipient=provider&page=7#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

363 matching records · $30,225.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 363 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 301–350 of 363.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $1.5602/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131330326 CMS
Janssen Biotech, Inc. $18.6202/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078780966 CMS
Mirati Therapeutics, Inc. $15.3702/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117172044 CMS
E.R. Squibb & Sons, L.L.C. $18.6802/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565867 CMS
E.R. Squibb & Sons, L.L.C. $0.8102/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565871 CMS
Merck Sharp & Dohme LLC $12.5302/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141955305 CMS
Eisai Inc. $24.1302/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110767917 CMS
Fresenius Kabi USA, LLC $16.2102/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146950544 CMS
AstraZeneca Pharmaceuticals LP $16.3602/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104589970 CMS
AstraZeneca Pharmaceuticals LP $23.3002/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104673201 CMS
E.R. Squibb & Sons, L.L.C. $21.0102/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565860 CMS
Novartis Pharmaceuticals Corporation $14.1102/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086779489 CMS
Celgene Corporation $10.5702/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101156268 CMS
Genentech USA, Inc. $22.2302/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133075282 CMS
OnMark, Inc. $350.0002/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840470 CMS
PFIZER INC. $25.0402/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131193803 CMS
Incyte Corporation $17.7402/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141255640 CMS
E.R. Squibb & Sons, L.L.C. $1.0002/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565849 CMS
E.R. Squibb & Sons, L.L.C. $0.2202/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565853 CMS
E.R. Squibb & Sons, L.L.C. $18.4002/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565856 CMS
Blueprint Medicines Corporation $21.1402/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147442720 CMS
Genentech USA, Inc. $13.1202/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133075274 CMS
Merck Sharp & Dohme LLC $21.0502/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141841186 CMS
PFIZER INC. $17.1002/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131286618 CMS
Celgene Corporation $25.8002/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101156272 CMS
ImmunoGen, Inc. $27.3702/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1099941363 CMS
E.R. Squibb & Sons, L.L.C. $15.8602/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101565846 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.0102/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144952899 CMS
Karyopharm Therapeutics Inc. $13.6602/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145534036 CMS
PFIZER INC. $19.4902/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131281861 CMS
Merck Sharp & Dohme LLC $25.2301/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141610500 CMS
Daiichi Sankyo Inc. $28.8801/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089394176 CMS
OnMark, Inc. $7,000.0001/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840466 CMS
OnMark, Inc. $1,400.0001/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840468 CMS
Celgene Corporation $20.1501/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101156266 CMS
Gilead Sciences, Inc. $22.1201/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133803072 CMS
OnMark, Inc. $37.4101/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840500 CMS
OnMark, Inc. $157.8901/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840462 CMS
OnMark, Inc. $88.0001/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840456 CMS
OnMark, Inc. $72.0001/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1084840460 CMS
AstraZeneca Pharmaceuticals LP $43.0901/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104692626 CMS
Daiichi Sankyo Inc. $13.5901/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089394166 CMS
Pharming Healthcare, Inc. $14.6401/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132141527 CMS
AstraZeneca Pharmaceuticals LP $18.0701/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105639772 CMS
EMD Serono, Inc. $32.8601/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120226407 CMS
Daiichi Sankyo Inc. $3.9501/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089394168 CMS
SOBI, INC $34.9901/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141416622 CMS
ABBVIE INC. $13.7801/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103235521 CMS
Daiichi Sankyo Inc. $17.1301/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089394174 CMS
SOBI, INC $33.8301/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141415844 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $23,753.83 242
PY2020 $15,215.54 172
PY2021 $11,242.29 277
PY2022 $26,904.11 377
PY2023 $14,017.56 417
PY2024 $30,225.60 363
PY2025 $9,837.92 354

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $15,744.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $1,400.00 11/14/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404376
Principal investigator 1 Genentech, Inc. $528.00 10/08/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404374
Principal investigator 1 Genentech, Inc. $9,033.00 09/18/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404372
Principal investigator 1 Genentech, Inc. $267.00 07/16/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404370
Principal investigator 1 Genentech, Inc. $4,516.00 04/04/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404368